Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best AI stocks under $50 to buy right now. On May 6, Recursion reported significant progress across its AI-driven clinical pipeline for Q1 ...
UIUC and Stanford's RecursiveMAS lets AI agents collaborate in embedding space instead of text, cutting token usage by 75% and speeding inference 2.4x.
Compare top AI app builders for prototyping, mobile apps, internal tools, backend depth, security, pricing, and code ...
The real headline is what ZAYA1-8B was trained on: a full stack of AMD Instinct MI300 graphics processing units (GPUs), the rival to Nvidia GPUs.
Three humans, eight AI team members, one product. The multi-agent collaboration pattern Stark Insider readers have been ...
Google reported the first confirmed AI-assisted zero-day exploit, raising new concerns about logic flaws, supply chain risk, and containment.
New Mercer research spoke to about 12,000 executives and found that they expect some serious organisational design changes ...
As competitor search engines surge on Google's AI obsession, Microsoft has a very, very rare opportunity to exploit the ...
Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
In The Lancet in 1971, Julian Tudor Hart gave medicine one of its most important insights: the availability of medical care ...